$0.89
1.26% yesterday
Nasdaq, Sep 16, 10:00 pm CET
ISIN
US64130M2098
Symbol
NMTC

NeuroOne Medical Technologies Corp Stock price

$0.89
+0.06 7.36% 1M
-0.19 17.49% 6M
+0.07 7.89% YTD
+0.08 9.67% 1Y
-1.07 54.54% 3Y
-2.35 72.50% 5Y
-0.76 45.99% 10Y
-0.76 45.99% 20Y
Nasdaq, Closing price Tue, Sep 16 2025
+0.01 1.26%

Key metrics

Basic
Market capitalization
$44.6m
Enterprise Value
$37.6m
Net debt
positive
Cash
$8.0m
Shares outstanding
49.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
4.6 | 5.1
EV/Sales
3.9 | 4.3
EV/FCF
negative
P/B
5.5
Financial Health
Equity Ratio
15.3%
Return on Equity
-1,498.6%
ROCE
-60.4%
ROIC
-
Debt/Equity
0.1
Financials (TTM | estimate)
Revenue
$9.6m | $8.7m
EBITDA
$-5.4m | $-13.6m
EBIT
$-5.7m | $-5.8m
Net Income
$-5.3m | $-6.6m
Free Cash Flow
$-4.1m
Growth (TTM | estimate)
Revenue
143.2% | 152.2%
EBITDA
54.9% | -16.6%
EBIT
53.6% | 51.6%
Net Income
55.9% | 46.4%
Free Cash Flow
64.1%
Margin (TTM | estimate)
Gross
70.1%
EBITDA
-56.2% | -155.9%
EBIT
-58.9%
Net
-55.4% | -75.9%
Free Cash Flow
-42.5%
More
EPS
$-0.1
FCF per Share
$-0.1
Short interest
0.4%
Employees
17
Rev per Employee
$200.0k
Show more

Is NeuroOne Medical Technologies Corp a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,016 stocks worldwide.

NeuroOne Medical Technologies Corp Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a NeuroOne Medical Technologies Corp forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a NeuroOne Medical Technologies Corp forecast:

Buy
86%
Hold
14%

Financial data from NeuroOne Medical Technologies Corp

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
9.63 9.63
143% 143%
100%
- Direct Costs 2.88 2.88
3% 3%
30%
6.75 6.75
477% 477%
70%
- Selling and Administrative Expenses 7.45 7.45
2% 2%
77%
- Research and Development Expense 4.98 4.98
13% 13%
52%
-5.41 -5.41
55% 55%
-56%
- Depreciation and Amortization 0.26 0.26
8% 8%
3%
EBIT (Operating Income) EBIT -5.67 -5.67
54% 54%
-59%
Net Profit -5.34 -5.34
56% 56%
-55%

In millions USD.

Don't miss a Thing! We will send you all news about NeuroOne Medical Technologies Corp directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

NeuroOne Medical Technologies Corp Stock News

Neutral
GlobeNewsWire
8 days ago
EDEN PRAIRIE, Minn., Sept. 08, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will be participating in the Sidoti & Co. Virtual Small-Cap Conference being held September 17-18, 2025.
Neutral
GlobeNewsWire
30 days ago
FDA Clearance Further Validates Technology Platform and Offers Alternatives to Pharmaceutical and Invasive Surgical Treatments
Neutral
Seeking Alpha
about one month ago
Protalix BioTherapeutics, Inc. (PLX) Q3 2025 Earnings Call August 14, 2025 8:30 AM ET Company Participants David A. Rosa - President, CEO & Director Ronald W.
More NeuroOne Medical Technologies Corp News

Company Profile

NeuroOne Medical Technologies Corp. operates as a medical technology company. It focuses on development and commercialization of thin film electrode technology for cEEG and sEEG recording, brain stimulation and ablation solutions for patients suffering from brain related disorders. The company was founded on August 20, 2009 and is headquartered in Eden Prairie, MN.

Head office United States
CEO David Rosa
Employees 17
Founded 2009
Website nmtc1.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today